Wird geladen...

Epoetin Biosimilars in the Treatment of Chemotherapy-Induced Anemia: 10 Years’ Experience Gained

High-quality, safe, and effective biosimilars have the potential to increase access to biological therapies worldwide and to reduce cancer care costs. The European Medicines Agency (EMA) was the first regulatory authority to establish legislative procedures for the approval of biosimilars when they...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BioDrugs
Hauptverfasser: Aapro, Matti, Krendyukov, Andriy, Schiestl, Martin, Gascón, Pere
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer International Publishing 2018
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5878200/
https://ncbi.nlm.nih.gov/pubmed/29417431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-018-0262-9
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!